Livestock 2.0: Harnessing the CRISPR-Cas9 Toolbox to Secure Global Food Systems

To address the rising demand for animal protein, the FAO projects that global meat and milk production must increase by 76% and 63%, respectively. Traditional livestock breeding, cloning, and artificial embryo transfers face severe structural constraints, including prolonged generation intervals, low selection efficiency, and a lack of control over specific traits. Furthermore, conventional disease management relying on antibiotics has led to environmental contamination and the dangerous spread of antimicrobial resistance. In light of these challenges, CRISPR-Cas9 has emerged as the premier genome-editing platform, surpassing older tools like Zinc-Finger Nucleases (ZFNs) and TALENs by being cheaper, simpler to design, faster to develop, and uniquely capable of targeting multiple genes simultaneously (multiplexing).Operating as programmable "molecular scissors" that combine guide RNA with Cas9 nucleases to introduce site-specific double-strand breaks, this technology is actively transforming agricultural and biomedical traits. While the potential of CRISPR-Cas9 is virtually limitless, the industry faces severe challenges. These include complex intellectual property patent landscapes, public uncertainty regarding the safety and consumption of genetically edited agricultural products, and regulatory constraints. Because precisely edited animals contain no foreign DNA footprints, they are virtually indistinguishable from natural variants, making market detection highly difficult. Moving forward, to secure a global market, developers must prioritize rigorous safety testing using Whole-Genome Sequencing (WGS) to identify unintended off-target mutations, establish science-based regulatory frameworks, and lead transparent, open public dialogues to foster societal trust and acceptance.